Among the different existing receptor subtypes, the homomeric α7 nAChR has attracted considerable attention because of its possible implication in several neurological and psychiatric disorders, including cognitive decline associated with Alzheimer's disease or schizophrenia. The gene discussed is CHRNA7; the disease is early-onset autosomal dominant Alzheimer disease.